These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24137771)

  • 1. Dr. Petri, et al reply.
    Petri M; Norman GL; Binder W; Shums Z; Akhter E; Fang H
    J Rheumatol; 2013 Sep; 40(9):1621. PubMed ID: 24137771
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
    Bertolaccini ML; Sciascia S; Murru V; Garcia-Fernandez C; Sanna G; Khamashta MA
    Thromb Haemost; 2013 Feb; 109(2):207-13. PubMed ID: 23254928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine and the antiphospholipid syndrome: what is the future?
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Clin Rheumatol; 2020 Apr; 39(4):1015-1017. PubMed ID: 32060811
    [No Abstract]   [Full Text] [Related]  

  • 4. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
    Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
    Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphosphatidylserine/prothrombin antibodies in systemic lupus erythematosus.
    Bertolaccini ML; Sciascia S; Sanna G; Khamashta MA
    J Rheumatol; 2013 Sep; 40(9):1620. PubMed ID: 23996998
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Kitani T; Iwatani Y; Kanakura Y
    Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
    Kopytek M; Natorska J; Undas A
    Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C.
    Galli M; Willems GM; Rosing J; Janssen RM; Govers-Riemslag JW; Comfurius P; Barbui T; Zwaal RF; Bevers EM
    Br J Haematol; 2005 Apr; 129(2):240-7. PubMed ID: 15813852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
    J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid levels in primary antiphospholipid syndrome.
    Carvalho JF; Shoenfeld Y
    Lupus; 2021 Nov; 30(13):2176-2178. PubMed ID: 34569385
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.